Monopar Therapeutics, Inc. (MNPR)
74.60
-2.44
(-3.17%)
USD |
NASDAQ |
Dec 12, 16:00
74.46
-0.14
(-0.19%)
After-Hours: 20:00
Monopar Therapeutics Total Liabilities (Quarterly): 2.639M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 202.66M |
| Travere Therapeutics, Inc. | 465.02M |
| Xenetic Biosciences, Inc. | 1.112M |
| KalVista Pharmaceuticals, Inc. | 322.93M |
| BeyondSpring, Inc. | 49.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 144.20M |
| Shareholders Equity (Quarterly) | 141.56M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 56.10 |
| Net Debt Paydown Yield | -0.00% |